| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $0.2435 (Miss by $-0.0014) |
| EPS GAAP Actual | $0.2435 (Miss by $-0.0014) |
| Revenue Actual | $2.74B |
| Revenue Surprise | Beat by $2740M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 3 |
| Dec 2028 | 0.46274 | 21.02 | 0.45989 | 0.46518 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 0.0892 | 0.0892 | 2.74B | -6.53% | 2740M |
| FQ2 2025 (Jun 2025) | 0.0892 | 0.0892 | 2.74B | -1.28% | 2740M |
| FQ4 2024 (Dec 2024) | 0.0251 | 0.0251 | 2.759B | -0.25% | 2759M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 2.78B | -0.65% | 2780M |
| FQ2 2024 (Jun 2024) | 0.033 | 0.033 | 2.775B | 0.83% | 2775M |
| FQ1 2021 (Mar 2021) | 0.0252 | 0.0252 | 2.306B | 100% | 2306M |
| FQ2 2021 (Jun 2021) | 0.0278 | 0.0278 | 2.269B | 100% | 2269M |
| FQ1 2024 (Mar 2024) | 0.046 | 0.046 | 2.919B | 100% | 2919M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 0.19619 | -- | 0.19261 | 0.19928 | 1 |
| FQ2 2028 (May 2028) | 0.19739 | -- | 0.19379 | 0.2005 | 1 |
| FQ1 2028 (Feb 2028) | 0.17377 | -- | 0.1706 | 0.17651 | 1 |
| FQ4 2027 (Nov 2027) | 0.18346 | -- | 0.18011 | 0.18635 | 1 |
| FQ3 2027 (Aug 2027) | 0.18674 | -- | 0.18333 | 0.18968 | 1 |
| FQ2 2027 (May 2027) | 0.17669 | -- | 0.17346 | 0.17947 | 1 |
| FQ1 2027 (Feb 2027) | 0.1878 | -- | 0.18437 | 0.19076 | 1 |
| FQ4 2026 (Nov 2026) | 0.08026172 | -- | 0.07879665 | 0.08152655 | 1 |
| FQ3 2026 (Aug 2026) | 0.16546 | -- | 0.16244 | 0.16807 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 7.33B | -- | 7.23B | 7.42B | 1 |
| FQ2 2028 (May 2028) | 7.48B | -- | 7.37B | 7.57B | 1 |
| FQ1 2028 (Feb 2028) | 6.91B | -- | 6.82B | 7B | 1 |
| FQ4 2027 (Nov 2027) | 7.31B | -- | 7.2B | 7.39B | 2 |
| FQ3 2027 (Aug 2027) | 7.03B | -- | 6.94B | 7.12B | 2 |
| FQ2 2027 (May 2027) | 7.06B | -- | 6.96B | 7.15B | 2 |
| FQ1 2027 (Feb 2027) | 6.8B | -- | 6.7B | 6.88B | 2 |
| FQ4 2026 (Nov 2026) | 3.19B | -- | 3.17B | 3.22B | 3 |
| FQ3 2026 (Aug 2026) | 6.41B | -- | 6.37B | 6.42B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 0.0892 | 0.0892 | 100% | |
| FQ2 2025 (Jun 2025) | 0.0892 | 0.0892 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0251 | 0.0251 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.033 | 0.033 | 100% | |
| FQ1 2021 (Mar 2021) | 0.0252 | 0.0252 | 100% | |
| FQ2 2021 (Jun 2021) | 0.0278 | 0.0278 | 100% | |
| FQ1 2024 (Mar 2024) | 0.046 | 0.046 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0B | $2.74B | $2740M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.74B | $2740M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.76B | $2759M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.78B | $2780M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.78B | $2775M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $2.31B | $2306M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $2.27B | $2269M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.92B | $2919M | 100% |